Group | Average body-weight gain (g) | Relative body-weight gain (%) | Mean lesion scores | Decreased oocyst output (%) | ACI |
---|---|---|---|---|---|
Unchallenged control | 98.26 ± 13.09e | 100 | 0 ± 0a | 100.00 | 200 |
Challenged control | 37.72 ± 41.47a | 40.91 | 3.05 ± 0.84f | 0.00 | 70.41 |
pVAX1 control | 41.47 ± 27.85ab | 43.81 | 2.60 ± 1.16e | 17.95 | 77.81 |
Pool 8–2–1 | 41.98 ± 26.55ab | 45.34 | 2.00 ± 1.19d | 75.64 | 120.34 |
Pool 8–2–2 | 79.85 ± 40.00d | 84.74 | 1.02 ± 1.25b | 61.54 | 164.54 |
Pool 8–2–3 | 54.62 ± 42.72bc | 59.28 | 2.12 ± 1.17d | 65.38 | 128.08 |
Pool 8–2–4 | 44.65 ± 30.68ab | 46.35 | 2.30 ± 1.12de | 71.79 | 113.35 |
Pool 8–2–5 | 43.87 ± 28.02ab | 47.15 | 1.37 ± 1.07bc | 43.59 | 113.45 |
Pool 8–2–6 | 51.47 ± 25.97bc | 55.58 | 2.10 ± 1.29d | 62.82 | 124.58 |
Pool 8–2–7 | 55.07 ± 26.63c | 56.80 | 2.32 ± 1.09de | 64.10 | 123.6 |
Pool 8–2–8 | 73.93 ± 30.41d | 82.93 | 1.45 ± 1.35c | 84.62 | 163.43 |
Pool 8–2–9 | 45.56 ± 38.25abc | 50.20 | 2.55 ± 0.95e | 62.82 | 114.7 |